Cargando…

Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur

BACKGROUND & OBJECTIVES: Primary or idiopathic osteonecrosis of femur head (ONFH) is the second most commonly observed cause among Indian patients suffering from ischemic ONFH. Although a number of genetic polymorphisms have been associated with idiopathic ONFH pathogenesis in Korean and Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Raman, Srishty, Dada, Rima, Nag, Tapas Chandra, Yadav, Chandra Shekhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347242/
https://www.ncbi.nlm.nih.gov/pubmed/35662090
http://dx.doi.org/10.4103/ijmr.IJMR_496_19
_version_ 1784761820920152064
author Raman, Srishty
Dada, Rima
Nag, Tapas Chandra
Yadav, Chandra Shekhar
author_facet Raman, Srishty
Dada, Rima
Nag, Tapas Chandra
Yadav, Chandra Shekhar
author_sort Raman, Srishty
collection PubMed
description BACKGROUND & OBJECTIVES: Primary or idiopathic osteonecrosis of femur head (ONFH) is the second most commonly observed cause among Indian patients suffering from ischemic ONFH. Although a number of genetic polymorphisms have been associated with idiopathic ONFH pathogenesis in Korean and Chinese populations, there are no studies in the Indian population. This is an exploratory study designed to implicate in promoter sequence polymorphisms of a critical fibrinolytic system regulator, plasminogen activator inhibitor-1 (PAI-1) gene, in cases of idiopathic osteonecrosis. Promoter sequence variations can affect expression levels of PAI-1 gene and may disrupt the coagulation/fibrinolytic equilibrium, which may finally culminate into osteonecrosis. Hence, the aim of the study was to investigate the role of single-nucleotide polymorphisms (SNPs) in the promoter region of PAI-1 gene and osteonecrosis development. METHODS: Two SNPs of the PAI-1 gene (rs2227631, -844 G/A; rs1799889, -675 4G/5G) were genotyped in 25 patients diagnosed with idiopathic ONFH and 25 control subjects, using direct sequencing. Subsequently, association analyses were performed for the genotyped SNPs. RESULTS: Both the rs2227631 and rs1799889 genotype and allele frequencies of PAI-1 gene showed an insignificant association with osteonecrosis risk (P=0.717, 0.149). Haplotype frequencies of rs2227631 and rs1799889 were also calculated in patients having idiopathic ONFH and controls. Although the distribution of haplotype GA-4G 4G was found to be the highest among the cases, it was not significantly different when compared with the controls. INTERPRETATION & CONCLUSIONS: Our findings demonstrate that the minor alleles of promoter region sequences of the PAI-1 gene do not contribute to an increase in ONFH predisposition. However, this is a preliminary study and its findings should be considered as suggestive for studies to be done in a larger sample size.
format Online
Article
Text
id pubmed-9347242
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93472422022-08-04 Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur Raman, Srishty Dada, Rima Nag, Tapas Chandra Yadav, Chandra Shekhar Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Primary or idiopathic osteonecrosis of femur head (ONFH) is the second most commonly observed cause among Indian patients suffering from ischemic ONFH. Although a number of genetic polymorphisms have been associated with idiopathic ONFH pathogenesis in Korean and Chinese populations, there are no studies in the Indian population. This is an exploratory study designed to implicate in promoter sequence polymorphisms of a critical fibrinolytic system regulator, plasminogen activator inhibitor-1 (PAI-1) gene, in cases of idiopathic osteonecrosis. Promoter sequence variations can affect expression levels of PAI-1 gene and may disrupt the coagulation/fibrinolytic equilibrium, which may finally culminate into osteonecrosis. Hence, the aim of the study was to investigate the role of single-nucleotide polymorphisms (SNPs) in the promoter region of PAI-1 gene and osteonecrosis development. METHODS: Two SNPs of the PAI-1 gene (rs2227631, -844 G/A; rs1799889, -675 4G/5G) were genotyped in 25 patients diagnosed with idiopathic ONFH and 25 control subjects, using direct sequencing. Subsequently, association analyses were performed for the genotyped SNPs. RESULTS: Both the rs2227631 and rs1799889 genotype and allele frequencies of PAI-1 gene showed an insignificant association with osteonecrosis risk (P=0.717, 0.149). Haplotype frequencies of rs2227631 and rs1799889 were also calculated in patients having idiopathic ONFH and controls. Although the distribution of haplotype GA-4G 4G was found to be the highest among the cases, it was not significantly different when compared with the controls. INTERPRETATION & CONCLUSIONS: Our findings demonstrate that the minor alleles of promoter region sequences of the PAI-1 gene do not contribute to an increase in ONFH predisposition. However, this is a preliminary study and its findings should be considered as suggestive for studies to be done in a larger sample size. Wolters Kluwer - Medknow 2021-12 /pmc/articles/PMC9347242/ /pubmed/35662090 http://dx.doi.org/10.4103/ijmr.IJMR_496_19 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Raman, Srishty
Dada, Rima
Nag, Tapas Chandra
Yadav, Chandra Shekhar
Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
title Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
title_full Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
title_fullStr Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
title_full_unstemmed Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
title_short Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
title_sort plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347242/
https://www.ncbi.nlm.nih.gov/pubmed/35662090
http://dx.doi.org/10.4103/ijmr.IJMR_496_19
work_keys_str_mv AT ramansrishty plasminogenactivatorinhibitor1promotersequencevariationsinidiopathicosteonecrosisofheadoffemur
AT dadarima plasminogenactivatorinhibitor1promotersequencevariationsinidiopathicosteonecrosisofheadoffemur
AT nagtapaschandra plasminogenactivatorinhibitor1promotersequencevariationsinidiopathicosteonecrosisofheadoffemur
AT yadavchandrashekhar plasminogenactivatorinhibitor1promotersequencevariationsinidiopathicosteonecrosisofheadoffemur